APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Steroid APIs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Steroid APIs Industry Growth and Trends Forecast to 2032

Report ID 174037870120 December 202596 pages

Choose your research edition.

Industry ResearchSteroid APIs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Steroid APIs Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Steroid APIs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Steroid APIs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Steroid APIs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Steroid APIs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Steroid APIs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Steroid APIs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Steroid APIs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Steroid APIs include Zhejiang Xianju Pharmaceutical, Tianjin Tianyao Pharmaceutical, Sanofi, MSD, Tianjin Jinjin Pharmaceutical, Pfizer, Henan LIHUA Pharmaceutical, Bayer and Steroid, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Steroid APIs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Steroid APIs market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Steroid APIs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Steroid APIs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Steroid APIs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Steroid APIs Market by Company

Zhejiang Xianju Pharmaceutical

Tianjin Tianyao Pharmaceutical

Sanofi

MSD

Tianjin Jinjin Pharmaceutical

Pfizer

Henan LIHUA Pharmaceutical

Bayer

Steroid

Steroid APIs Segment by Type

Estrogens

Anabolics

Corticosteroids

Progestinics

Others

Steroid APIs Segment by Application

Industrial

Laboratory

Steroid APIs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Steroid APIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Steroid APIs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Steroid APIs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Steroid APIs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Steroid APIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Estrogens Table 2. Major Company of Anabolics Table 3. Major Company of Corticosteroids Table 4. Major Company of Progestinics Table 5. Major Company of Others Table 6. Global Steroid APIs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Steroid APIs Sales by Type (2021-2026) & (tons) Table 8. Global Steroid APIs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Steroid APIs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Steroid APIs Sales Market Share in Value by Type (2021-2026) Table 11. Global Steroid APIs Price by Type (2021-2026) & (US$/ton) Table 12. Global Steroid APIs Sales by Type (2027-2032) & (tons) Table 13. Global Steroid APIs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Steroid APIs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Steroid APIs Sales Market Share in Value by Type (2027-2032) Table 16. Global Steroid APIs Price by Type (2027-2032) & (US$/ton) Table 17. North America Steroid APIs Sales by Type (2021-2026) & (tons) Table 18. North America Steroid APIs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Steroid APIs Sales by Type (2021-2026) & (tons) Table 20. Europe Steroid APIs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Steroid APIs Sales by Type (2021-2026) & (tons) Table 22. Asia-Pacific Steroid APIs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Steroid APIs Sales by Type (2021-2026) & (tons) Table 24. Latin America Steroid APIs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Steroid APIs Sales by Type (2021-2026) & (tons) Table 26. Middle East and Africa Steroid APIs Sales by Type (2021-2026) & (US$ Million) Table 27. Steroid APIs Industry Trends Table 28. Steroid APIs Industry Drivers Table 29. Steroid APIs Industry Opportunities and Challenges Table 30. Steroid APIs Industry Restraints Table 31. Global Steroid APIs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Steroid APIs Revenue Market Share by Company (2021-2026) Table 33. Global Steroid APIs Sales by Company (2021-2026) & (tons) Table 34. Global Steroid APIs Sales Share by Company (2021-2026) Table 35. Global Steroid APIs Market Price by Company (2021-2026) & (US$/ton) Table 36. Global Steroid APIs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Steroid APIs Major Company Production Sites and Headquarters Table 38. Global Steroid APIs Company, Product Type & Application Table 39. Global Steroid APIs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Steroid APIs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Steroid APIs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Steroid APIs Sales by Region (2021-2026) & (tons) Table 44. Global Steroid APIs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Steroid APIs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Steroid APIs Sales Market Share in Value by Region (2021-2026) Table 47. Global Steroid APIs Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 48. Global Steroid APIs Sales by Region (2027-2032) & (tons) Table 49. Global Steroid APIs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Steroid APIs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Steroid APIs Sales Market Share in Value by Region (2027-2032) Table 52. Global Steroid APIs Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 53. Global Steroid APIs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Steroid APIs Sales by Application (2021-2026) & (tons) Table 55. Global Steroid APIs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Steroid APIs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Steroid APIs Sales Market Share in Value by Application (2021-2026) Table 58. Global Steroid APIs Price by Application (2021-2026) & (US$/ton) Table 59. Global Steroid APIs Sales by Application (2027-2032) & (tons) Table 60. Global Steroid APIs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Steroid APIs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Steroid APIs Sales Market Share in Value by Application (2027-2032) Table 63. Global Steroid APIs Price by Application (2027-2032) & (US$/ton) Table 64. North America Steroid APIs Sales by Application (2021-2026) & (tons) Table 65. North America Steroid APIs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Steroid APIs Sales by Application (2021-2026) & (tons) Table 67. Europe Steroid APIs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Steroid APIs Sales by Application (2021-2026) & (tons) Table 69. Asia-Pacific Steroid APIs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Steroid APIs Sales by Application (2021-2026) & (tons) Table 71. Latin America Steroid APIs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Steroid APIs Sales by Application (2021-2026) & (tons) Table 73. Middle East and Africa Steroid APIs Sales by Application (2021-2026) & (US$ Million) Table 74. Zhejiang Xianju Pharmaceutical Company Information Table 75. Zhejiang Xianju Pharmaceutical Business Overview Table 76. Zhejiang Xianju Pharmaceutical Steroid APIs Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 77. Zhejiang Xianju Pharmaceutical Steroid APIs Product Portfolio Table 78. Zhejiang Xianju Pharmaceutical Recent Development Table 79. Tianjin Tianyao Pharmaceutical Company Information Table 80. Tianjin Tianyao Pharmaceutical Business Overview Table 81. Tianjin Tianyao Pharmaceutical Steroid APIs Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 82. Tianjin Tianyao Pharmaceutical Steroid APIs Product Portfolio Table 83. Tianjin Tianyao Pharmaceutical Recent Development Table 84. Sanofi Company Information Table 85. Sanofi Business Overview Table 86. Sanofi Steroid APIs Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 87. Sanofi Steroid APIs Product Portfolio Table 88. Sanofi Recent Development Table 89. MSD Company Information Table 90. MSD Business Overview Table 91. MSD Steroid APIs Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 92. MSD Steroid APIs Product Portfolio Table 93. MSD Recent Development Table 94. Tianjin Jinjin Pharmaceutical Company Information Table 95. Tianjin Jinjin Pharmaceutical Business Overview Table 96. Tianjin Jinjin Pharmaceutical Steroid APIs Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 97. Tianjin Jinjin Pharmaceutical Steroid APIs Product Portfolio Table 98. Tianjin Jinjin Pharmaceutical Recent Development Table 99. Pfizer Company Information Table 100. Pfizer Business Overview Table 101. Pfizer Steroid APIs Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 102. Pfizer Steroid APIs Product Portfolio Table 103. Pfizer Recent Development Table 104. Henan LIHUA Pharmaceutical Company Information Table 105. Henan LIHUA Pharmaceutical Business Overview Table 106. Henan LIHUA Pharmaceutical Steroid APIs Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 107. Henan LIHUA Pharmaceutical Steroid APIs Product Portfolio Table 108. Henan LIHUA Pharmaceutical Recent Development Table 109. Bayer Company Information Table 110. Bayer Business Overview Table 111. Bayer Steroid APIs Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 112. Bayer Steroid APIs Product Portfolio Table 113. Bayer Recent Development Table 114. Steroid Company Information Table 115. Steroid Business Overview Table 116. Steroid Steroid APIs Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 117. Steroid Steroid APIs Product Portfolio Table 118. Steroid Recent Development Table 119. North America Steroid APIs Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 120. North America Steroid APIs Sales by Country (2021-2026) & (tons) Table 121. North America Steroid APIs Sales Market Share by Country (2021-2026) Table 122. North America Steroid APIs Sales Forecast by Country (2027-2032) & (tons) Table 123. North America Steroid APIs Sales Market Share Forecast by Country (2027-2032) Table 124. North America Steroid APIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. North America Steroid APIs Market Size by Country (2021-2026) & (US$ Million) Table 126. North America Steroid APIs Market Share by Country (2021-2026) Table 127. North America Steroid APIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. North America Steroid APIs Market Share Forecast by Country (2027-2032) Table 129. Europe Steroid APIs Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 130. Europe Steroid APIs Sales by Country (2021-2026) & (tons) Table 131. Europe Steroid APIs Sales Market Share by Country (2021-2026) Table 132. Europe Steroid APIs Sales Forecast by Country (2027-2032) & (tons) Table 133. Europe Steroid APIs Sales Market Share Forecast by Country (2027-2032) Table 134. Europe Steroid APIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Europe Steroid APIs Market Size by Country (2021-2026) & (US$ Million) Table 136. Europe Steroid APIs Market Share by Country (2021-2026) Table 137. Europe Steroid APIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Europe Steroid APIs Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Steroid APIs Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Steroid APIs Sales by Country (2021-2026) & (tons) Table 141. Asia-Pacific Steroid APIs Sales Market Share by Country (2021-2026) Table 142. Asia-Pacific Steroid APIs Sales Forecast by Country (2027-2032) & (tons) Table 143. Asia-Pacific Steroid APIs Sales Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Steroid APIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Steroid APIs Market Size by Country (2021-2026) & (US$ Million) Table 146. Asia-Pacific Steroid APIs Market Share by Country (2021-2026) Table 147. Asia-Pacific Steroid APIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Asia-Pacific Steroid APIs Market Share Forecast by Country (2027-2032) Table 149. Latin America Steroid APIs Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 150. Latin America Steroid APIs Sales by Country (2021-2026) & (tons) Table 151. Latin America Steroid APIs Sales Market Share by Country (2021-2026) Table 152. Latin America Steroid APIs Sales Forecast by Country (2027-2032) & (tons) Table 153. Latin America Steroid APIs Sales Market Share Forecast by Country (2027-2032) Table 154. Latin America Steroid APIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Latin America Steroid APIs Market Size by Country (2021-2026) & (US$ Million) Table 156. Latin America Steroid APIs Market Share by Country (2021-2026) Table 157. Latin America Steroid APIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Latin America Steroid APIs Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Steroid APIs Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Steroid APIs Sales by Country (2021-2026) & (tons) Table 161. Middle East and Africa Steroid APIs Sales Market Share by Country (2021-2026) Table 162. Middle East and Africa Steroid APIs Sales Forecast by Country (2027-2032) & (tons) Table 163. Middle East and Africa Steroid APIs Sales Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Steroid APIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Steroid APIs Market Size by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Steroid APIs Market Share by Country (2021-2026) Table 167. Middle East and Africa Steroid APIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Middle East and Africa Steroid APIs Market Share Forecast by Country (2027-2032) Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Steroid APIs Distributors List Table 172. Steroid APIs Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Steroid APIs Image Figure 2. Global Steroid APIs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Steroid APIs Market Size (2021-2032) & (US$ Million) Figure 4. Global Steroid APIs Sales (2021-2032) & (tons) Figure 5. Estrogens Image Figure 6. Global Estrogens Sales YoY Growth (2021-2032) & (tons) Figure 7. Anabolics Image Figure 8. Global Anabolics Sales YoY Growth (2021-2032) & (tons) Figure 9. Corticosteroids Image Figure 10. Global Corticosteroids Sales YoY Growth (2021-2032) & (tons) Figure 11. Progestinics Image Figure 12. Global Progestinics Sales YoY Growth (2021-2032) & (tons) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (tons) Figure 15. Global Steroid APIs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Steroid APIs Market Share by Type 2025 VS 2032 Figure 17. North America Steroid APIs Sales Market Share in Volume by Type in 2025 Figure 18. North America Steroid APIs Sales Market Share in Value by Type in 2025 Figure 19. Europe Steroid APIs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Steroid APIs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Steroid APIs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Steroid APIs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Steroid APIs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Steroid APIs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Steroid APIs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Steroid APIs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Steroid APIs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Industrial Image Figure 30. Global Industrial Sales YoY Growth (2021-2032) & (tons) Figure 31. Laboratory Image Figure 32. Global Laboratory Sales YoY Growth (2021-2032) & (tons) Figure 33. Global Steroid APIs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Steroid APIs Market Share by Application 2025 VS 2032 Figure 35. North America Steroid APIs Sales Market Share in Volume by Application in 2025 Figure 36. North America Steroid APIs Sales Market Share in Value by Application in 2025 Figure 37. Europe Steroid APIs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Steroid APIs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Steroid APIs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Steroid APIs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Steroid APIs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Steroid APIs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Steroid APIs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Steroid APIs Sales Market Share in Value by Application in 2025 Figure 45. North America Steroid APIs Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 46. North America Steroid APIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Steroid APIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Steroid APIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Steroid APIs Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 50. Europe Steroid APIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Steroid APIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Steroid APIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Steroid APIs Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 54. Asia-Pacific Steroid APIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Steroid APIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Steroid APIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Steroid APIs Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 58. Latin America Steroid APIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Steroid APIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Steroid APIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Steroid APIs Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 62. Middle East and Africa Steroid APIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Steroid APIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Steroid APIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Steroid APIs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Steroid APIs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Estrogens
  • Anabolics
  • Corticosteroids
  • Progestinics
  • Others
Applications
  • Industrial
  • Laboratory
Companies covered
  • Zhejiang Xianju Pharmaceutical
  • Tianjin Tianyao Pharmaceutical
  • Sanofi
  • MSD
  • Tianjin Jinjin Pharmaceutical
  • Pfizer
  • Henan LIHUA Pharmaceutical
  • Bayer
  • Steroid

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Steroid APIs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Steroid APIs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Steroid APIs Market by Type
  6. 1.3.1 Estrogens
  7. 1.3.2 Anabolics
  8. 1.3.3 Corticosteroids
  9. 1.3.4 Progestinics
  10. 1.3.5 Others
  11. 1.4 Global Steroid APIs Market Size by Type
  12. 1.4.1 Global Steroid APIs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Steroid APIs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Steroid APIs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Steroid APIs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Steroid APIs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Steroid APIs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Steroid APIs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Steroid APIs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Steroid APIs Industry Trends
  2. 2.2 Steroid APIs Industry Drivers
  3. 2.3 Steroid APIs Industry Opportunities and Challenges
  4. 2.4 Steroid APIs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Steroid APIs Revenue (2021-2026)
  2. 3.2 Global Top Players by Steroid APIs Sales (2021-2026)
  3. 3.3 Global Top Players by Steroid APIs Price (2021-2026)
  4. 3.4 Global Steroid APIs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Steroid APIs Major Company Production Sites & Headquarters
  6. 3.6 Global Steroid APIs Company, Product Type & Application
  7. 3.7 Global Steroid APIs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Steroid APIs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Steroid APIs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Steroid APIs Tier 1, Tier 2, and Tier 3
4 Steroid APIs Regional Status and Outlook
  1. 4.1 Global Steroid APIs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Steroid APIs Historic Market Size by Region
  3. 4.2.1 Global Steroid APIs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Steroid APIs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Steroid APIs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Steroid APIs Forecasted Market Size by Region
  7. 4.3.1 Global Steroid APIs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Steroid APIs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Steroid APIs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Steroid APIs by Application
  1. 5.1 Steroid APIs Market by Application
  2. 5.1.1 Industrial
  3. 5.1.2 Laboratory
  4. 5.2 Global Steroid APIs Market Size by Application
  5. 5.2.1 Global Steroid APIs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Steroid APIs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Steroid APIs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Steroid APIs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Steroid APIs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Steroid APIs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Steroid APIs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Steroid APIs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang Xianju Pharmaceutical
  2. 6.1.1 Zhejiang Xianju Pharmaceutical Company Information
  3. 6.1.2 Zhejiang Xianju Pharmaceutical Business Overview
  4. 6.1.3 Zhejiang Xianju Pharmaceutical Steroid APIs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Xianju Pharmaceutical Steroid APIs Product Portfolio
  6. 6.1.5 Zhejiang Xianju Pharmaceutical Recent Developments
  7. 6.2 Tianjin Tianyao Pharmaceutical
  8. 6.2.1 Tianjin Tianyao Pharmaceutical Company Information
  9. 6.2.2 Tianjin Tianyao Pharmaceutical Business Overview
  10. 6.2.3 Tianjin Tianyao Pharmaceutical Steroid APIs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Tianjin Tianyao Pharmaceutical Steroid APIs Product Portfolio
  12. 6.2.5 Tianjin Tianyao Pharmaceutical Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Steroid APIs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Steroid APIs Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 MSD
  20. 6.4.1 MSD Company Information
  21. 6.4.2 MSD Business Overview
  22. 6.4.3 MSD Steroid APIs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 MSD Steroid APIs Product Portfolio
  24. 6.4.5 MSD Recent Developments
  25. 6.5 Tianjin Jinjin Pharmaceutical
  26. 6.5.1 Tianjin Jinjin Pharmaceutical Company Information
  27. 6.5.2 Tianjin Jinjin Pharmaceutical Business Overview
  28. 6.5.3 Tianjin Jinjin Pharmaceutical Steroid APIs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Tianjin Jinjin Pharmaceutical Steroid APIs Product Portfolio
  30. 6.5.5 Tianjin Jinjin Pharmaceutical Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Steroid APIs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Steroid APIs Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Henan LIHUA Pharmaceutical
  38. 6.7.1 Henan LIHUA Pharmaceutical Company Information
  39. 6.7.2 Henan LIHUA Pharmaceutical Business Overview
  40. 6.7.3 Henan LIHUA Pharmaceutical Steroid APIs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Henan LIHUA Pharmaceutical Steroid APIs Product Portfolio
  42. 6.7.5 Henan LIHUA Pharmaceutical Recent Developments
  43. 6.8 Bayer
  44. 6.8.1 Bayer Company Information
  45. 6.8.2 Bayer Business Overview
  46. 6.8.3 Bayer Steroid APIs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bayer Steroid APIs Product Portfolio
  48. 6.8.5 Bayer Recent Developments
  49. 6.9 Steroid
  50. 6.9.1 Steroid Company Information
  51. 6.9.2 Steroid Business Overview
  52. 6.9.3 Steroid Steroid APIs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Steroid Steroid APIs Product Portfolio
  54. 6.9.5 Steroid Recent Developments
7 North America by Country
  1. 7.1 North America Steroid APIs Sales by Country
  2. 7.1.1 North America Steroid APIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Steroid APIs Sales by Country (2021-2026)
  4. 7.1.3 North America Steroid APIs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Steroid APIs Market Size by Country
  6. 7.2.1 North America Steroid APIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Steroid APIs Market Size by Country (2021-2026)
  8. 7.2.3 North America Steroid APIs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Steroid APIs Sales by Country
  2. 8.1.1 Europe Steroid APIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Steroid APIs Sales by Country (2021-2026)
  4. 8.1.3 Europe Steroid APIs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Steroid APIs Market Size by Country
  6. 8.2.1 Europe Steroid APIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Steroid APIs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Steroid APIs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Steroid APIs Sales by Country
  2. 9.1.1 Asia-Pacific Steroid APIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Steroid APIs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Steroid APIs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Steroid APIs Market Size by Country
  6. 9.2.1 Asia-Pacific Steroid APIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Steroid APIs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Steroid APIs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Steroid APIs Sales by Country
  2. 10.1.1 South America Steroid APIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Steroid APIs Sales by Country (2021-2026)
  4. 10.1.3 South America Steroid APIs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Steroid APIs Market Size by Country
  6. 10.2.1 South America Steroid APIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Steroid APIs Market Size by Country (2021-2026)
  8. 10.2.3 South America Steroid APIs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Steroid APIs Sales by Country
  2. 11.1.1 Middle East and Africa Steroid APIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Steroid APIs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Steroid APIs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Steroid APIs Market Size by Country
  6. 11.2.1 Middle East and Africa Steroid APIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Steroid APIs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Steroid APIs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Steroid APIs Value Chain Analysis
  2. 12.1.1 Steroid APIs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Steroid APIs Production Mode & Process
  7. 12.2 Steroid APIs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Steroid APIs Distributors
  10. 12.2.3 Steroid APIs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst